Golden Throat Holdings Group Company Limited

HK$1.95As of Sun 8 Nov 2026, 12:00 UTC
HKEX:6896Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 1.98%
Div yield 17.44%
ROE 17.87%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.18)
PE TTM 5.805
TSR TTM (36.97%)
Mkt cap HK$1.442B
ROIC 23.45%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.23
14.10%
22.51%
Hold 10|11|4|3|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.04
0.04
0.04
0.05
18.80%
8.52%
3.03%
12.94%
Revenue¥M
125.9
125.9
132.3
130.0
11.05%
13.75%
14.66%
6.98%
Peers (US$183.9M)
Cap (US$)
PE
167.8M
6.517x
Capital
TTM
5Y
10Y
Leveragex
0.120
0.254
0.234
EBIT/Intx
1.159
0.899
0.808
Own earn%
544.33
(57.06)
(54.56)
Sh yield%
14.40
25.99
24.25
Owners
Insiders/Inst%
11.03
40.02
Short interest%
3.16
SBC / revenue%
2.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
15–27
$1 testx
—
Incr. ROIC%
15